These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3858662

  • 1. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T, Mitchell T, Sariban E, Sabbath K, Griffin J, Kufe D.
    Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD, Quincoces AF, Gómez-Casares MT, Martínez CA, Cuadrado MA, Richard C, León J.
    Cancer Res; 1992 Nov 01; 52(21):5979-84. PubMed ID: 1394224
    [Abstract] [Full Text] [Related]

  • 4. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
    Kharbanda S, Emoto Y, Kisaki H, Saleem A, Kufe D.
    Mol Pharmacol; 1994 Jul 01; 46(1):67-72. PubMed ID: 8058058
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J, Hayashi M, Honma Y, Hozumi M.
    Cancer Res; 1986 Mar 01; 46(3):1239-43. PubMed ID: 3455882
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL, Wu RT.
    Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611
    [Abstract] [Full Text] [Related]

  • 9. Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells.
    Fukuda M.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4621-8. PubMed ID: 7306980
    [Abstract] [Full Text] [Related]

  • 10. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y, Onozuka Y, Okabe-Kado J, Kasukabe T, Hozumi M.
    Cancer Res; 1991 Sep 01; 51(17):4535-8. PubMed ID: 1873797
    [Abstract] [Full Text] [Related]

  • 11. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
    Tonini GP, Radzioch D, Gronberg A, Clayton M, Blasi E, Benetton G, Varesio L.
    Cancer Res; 1987 Sep 01; 47(17):4544-7. PubMed ID: 3476195
    [Abstract] [Full Text] [Related]

  • 12. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation.
    Mager D, Bernstein A.
    J Cell Physiol; 1980 Dec 01; 105(3):519-26. PubMed ID: 6936401
    [Abstract] [Full Text] [Related]

  • 13. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC, Wang Z, Li HX, Liu MJ, Wu RC, Wang XH.
    Acta Pharmacol Sin; 2004 Feb 01; 25(2):231-8. PubMed ID: 14769215
    [Abstract] [Full Text] [Related]

  • 14. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
    Watanabe T, Shafman T, Kufe DW.
    J Cell Physiol; 1985 Mar 01; 122(3):435-40. PubMed ID: 3918047
    [Abstract] [Full Text] [Related]

  • 15. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM, Miyazaki K, Takeyama H, Sherman ML, Spriggs DR, Carney WP, Kufe DW.
    Cancer Commun; 1989 Mar 01; 1(3):191-7. PubMed ID: 2639729
    [Abstract] [Full Text] [Related]

  • 16. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
    Nagasawa K, Howatson A, Mak TW.
    J Cell Physiol; 1981 Oct 01; 109(1):181-92. PubMed ID: 6976970
    [Abstract] [Full Text] [Related]

  • 17. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
    Fibach E, Gambari R, Shaw PA, Maniatis G, Reuben RC, Sassa S, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1979 Apr 01; 76(4):1906-10. PubMed ID: 287029
    [Abstract] [Full Text] [Related]

  • 18. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
    Henschler R, Brennscheidt U, Mertelsmann R, Herrmann F.
    Mol Pharmacol; 1991 Feb 01; 39(2):171-6. PubMed ID: 1996082
    [Abstract] [Full Text] [Related]

  • 19. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
    Mitchell T, Sariban E, Kufe D.
    Mol Pharmacol; 1986 Oct 01; 30(4):398-402. PubMed ID: 3531806
    [Abstract] [Full Text] [Related]

  • 20. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
    Asano Y, Brach MA, Ahlers A, de Vos S, Butterfield JH, Ashman LK, Valent P, Gruss HJ, Herrmann F.
    J Immunol; 1993 Sep 01; 151(5):2345-54. PubMed ID: 7689605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.